Athens Medical C.S.A. (ATH:IATR)

Market Cap	119.70M -26.8%
Revenue (ttm)	281.20M +3.8%
Net Income	-5.32M
EPS	-0.06
Shares Out	86.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.02 (1.45%)
Ex-Dividend Date	n/a

Volume	758
Open	1.380
Previous Close	1.380
Day's Range	1.380 - 1.380
52-Week Range	1.370 - 2.190
Beta	0.75
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 29, 2026

About Athens Medical C.S.A.

Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for breast, gastrointestinal, hematologic malignancies, lover and pancreatic, lung, prostate, and other common cancers; heart and vascular, robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injur...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1983
• Employees: 3,505
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: IATR

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 3, 2026

Data Sources Report a data error